SAS | The Power to Know
Backgrounds_84A0920
cq5dam.thumbnail.319.319
White Paper

Share and Share Alike

The Quest for Transparency for Clinical Trial Data

About this paper

Should life science companies be expected to share patient-level data from their clinical trials? Groups such as the European Medicines Agency and the AllTrials campaign say yes; it's in the public interest to do so. Forward-thinking companies are taking bold steps toward data sharing because it's also good business and good science. This article summarizes discussion on the topic with industry leaders at the Clinical Trial Data Transparency Forum, sponsored by SAS, held in October 2013.

About SAS

SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

Har du en SAS-profil? To complete this form automatically Logg inn

*
*
*
*
 
*
 
 
  Yes, I would like to receive occasional emails from SAS Institute Inc. and its affiliates about SAS products and services. I understand that I can withdraw my consent at any time by clicking the opt-out link in the emails.

All personlig informasjon vil bli behandlet i samsvar med SAS' personvernerklæring.

 
 

Back to Top